Abstract:This study examines in vivo the role and functional interrelationships of components regulating exit from the G1 resting phase into the DNA synthetic (S) phase of the cell cycle. Our approach made use of several key experimental attributes of the developing mouse lens, namely its strong dependence on pRb in maintenance of the postmitotic state, the down-regulation of cyclins D and E and up-regulation of the p57(KIP2) inhibitor in the postmitotic lens fiber cell compartment, and the ability to target transgene expression to this compartment. These attributes provide an ideal in vivo context in which to examine the consequences of forced cyclin expression and/or of loss of p57(KIP2) inhibitor function in a cellular compartment that permits an accurate quantitation of cellular proliferation and apoptosis rates in situ. Here, we demonstrate that, despite substantial overlap in cyclin transgene expression levels, D-type and E cyclins exhibited clear functional differences in promoting entry into S phase. In general, forced expression of the D-type cyclins was more efficient than cyclin E in driving lens fiber cells into S phase. In the case of cyclins D1 and D2, ectopic proliferation required their enhanced nuclear localization through CDK4 coexpression. High nuclear levels of cyclin E and CDK2, while not sufficient to promote efficient exit from G1, did act synergistically with ectopic cyclin D/CDK4. The functional differences between D-type and E cyclins was most evident in the p57(KIP2)-deficient lens wherein cyclin D overexpression induced a rate of proliferation equivalent to that of the pRb null lens, while overexpression of cyclin E did not increase the rate of proliferation over that induced by the loss of p57(KIP2) function. These in vivo analyses provide strong biological support for the prevailing view that the antecedent actions of cyclin D/CDK4 act cooperatively with cyclin E/CDK2 and antagonistically with p57(KIP2) to regulate the G1/S transition in a cell type highly dependent upon pRb.

Cyclin E in normal physiology and disease states

Down-regulation of Cyclin E Expression by Caffeine Promotes Cancer Cell Entry into the S-phase of the Cell Cycle.

Promotive Effect of Decreased Cyclin E Threshold on Cell Proliferation

Regulation of Cyclin E and Cancers

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

The double dealing of cyclin D1

The Requirement for Cyclin E in C-Myc Overexpressing Breast Cancers.

Targeting low molecular weight cyclin E (LMW-E) in breast cancer

Cell Cycle Progression Mechanisms: Slower Cyclin-D/cdk4 Activation and Faster Cyclin-E/cdk2.

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

CYCLINS AND CELL CYCLE CHECKPOINTS

The broken cycle: E2F dysfunction in cancer

Targeting CDK7 in oncology: The avenue forward.

Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation

Cyclins and cdks in development and cancer: a perspective

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo

Cyclin E Overexpression in the Drosophila Accessory Gland Induces Tissue Dysplasia.

Slower CDK4 and faster CDK2 activation in the cell cycle

Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma

Cell Cycle Regulation and Hematologic Malignancies

Stabilization of GTSE1 by cyclin D1-CDK4/6 promotes cell proliferation: relevance in cancer prognosis